… trials to summarize the efficacy of anti-obesity drugs in reducing BMI and improving health in
… anti-obesity drugs used in children and adolescents (age <20) with primary obesity for ≥6 …

… the efficacy and safety of liraglutide for the treatment of obesity ( Box 1 ). The materials
reviewed were identified by searching PubMed for publications using ‘liraglutide’ and ‘obesity’ as …

… on DOAC use in obese patients continue to raise concerns … in obese individuals without
NVAF or VTE, and PK, PD, efficacy, effectiveness, and safety data for apixaban in obese patients …

… In conclusion, URS is a safe and efficient treatment method for obese patients with urinary
tract stones, and has an increased efficiency with smaller stones, ie those <2 cm. URS also …

… anticoagulants (DOACs) in morbidly obese patients. We sought to examine the efficacy in
preventing stroke or other systemic embolic events and safety of apixaban, dabigatran, and …

… We compared the efficacy of weight reduction and the effects on blood glucose, blood lipids,
and blood pressure in overweight and obese patients in the TCM group and control group. …

… obese patients on a calorie-restricted diet. The weight loss in dextrofenfluramine-treated
patients … be in short term trials an effective and safe tool in overweight control in obese patients. …

… safety and efficacy of RYGB in this group of patients. The aim of this study is to assess …
safety and efficacy of RYGB in TD2M patients with BMI < 35 kg/m 2 . All T2DM patients with BMI < …

… require dose adjustments for obese patients, Citation18 the comparable efficacy and
tolerability profile of AOM 400 in obese and nonobese patients with schizophrenia supports the …

… with obesity or overweight was combined to analyze the efficacy and safety of liraglutide 3.0
mg in adults with obesity or … In terms of efficacy, with at least 1-year treatment, 60.7% of the …